Allergan CEO Brent Saunders thinks aesthetic medical treatments are the next big moneymaker — 4 key notes

Allergan's CEO Brent Saunders said on CNBC male millennials are revitalizing the aesthetic medical treatment market.

Here's what you should know:

1. While 30 million U.S. residents consider aesthetic treatments, only 3 million complete the procedures.

2. Mr. Saunders said within that 3 million however male millennials account for 25 percent of the market.

3. The emergence of the male millennial markets is new to aesthetic medicine, but Mr. Saunders said it's rapidly expanding.

4. Allergan's Botox was the company's sales leader last quarter. Allergan recently closed a $2.48 billion acquisition of Zeltiq. Zeltiq's primary product space is in medical aesthetics.

Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Learning Opportunities

Featured Webinars

Featured Whitepapers

Featured Podcast